Rybelsus vs Metformin: How They Compare for Type 2 Diabetes

Rybelsus (oral semaglutide) and metformin are both tablets for type 2 diabetes, but they work very differently. Metformin is the cheap, long-established first choice for most people. Rybelsus, the first GLP-1 pill, usually lowers blood sugar and weight more, and is now approved to lower heart risk too, but it costs far more and has strict rules for taking it. They are often used together.

• Metformin: reduces the liver’s sugar output and improves insulin sensitivity. It lowers HbA1c by roughly 1 to 1.5 points, is weight-neutral or causes slight weight loss, rarely causes lows on its own and costs very little as a generic.
• Rybelsus: a GLP-1 receptor agonist in tablet form. It lowers HbA1c by about 1 to 1.4 points at maintenance doses and usually brings 2 to 4 kg of weight loss. Since October 2025, it has also been approved to reduce heart attack, stroke and cardiovascular death in adults with type 2 diabetes at high cardiovascular risk.
• Tablet names changed: the original Rybelsus tablets are 3, 7 and 14 mg. A newer, better-absorbed version (1.5, 4 and 9 mg) is now sold as Ozempic tablets. They are not interchangeable milligram for milligram.
• How to take Rybelsus: on an empty stomach when you wake up, with no more than 4 oz (120 mL) of plain water, then wait at least 30 minutes before eating, drinking or taking other medicines.
• Main side effects: stomach upset with both. Metformin can lower vitamin B12 over time; Rybelsus carries a boxed warning about thyroid C-cell tumors seen in rodents.

This is general information, not medical advice. Don’t start, stop or swap diabetes medicines without speaking to your doctor or pharmacist.

Rybelsus vs metformin at a glance

	Rybelsus (oral semaglutide)	Metformin
Drug class	GLP-1 receptor agonist	Biguanide
First US approval	2019	1995 (used in Europe since the 1950s)
Doses	3 mg for 30 days, then 7 mg, then 14 mg if needed	Usually 500 mg to 2,000 mg a day (up to 2,550 mg immediate-release)
When to take	Once daily on waking, empty stomach	With meals, once or twice daily
Typical HbA1c drop	About 1.0 to 1.4 points	About 1.0 to 1.5 points
Weight	Loss of 2 to 4 kg on average	Neutral or slight loss
Heart outcomes	Lowered major cardiovascular events in SOUL trial	Long-standing evidence of benefit, mainly from older studies
Low blood sugar on its own	Rare	Rare
Boxed warning	Thyroid C-cell tumors (rodents)	Lactic acidosis
Cost	High (brand only)	Very low (generic)

How they work

Metformin

Metformin lowers blood sugar mainly by reducing how much glucose the liver releases, especially overnight. It also makes muscles more sensitive to insulin and acts in the gut. Because it doesn’t push the pancreas to release more insulin, it rarely causes hypoglycemia on its own.

Rybelsus

Semaglutide copies GLP-1, a gut hormone that boosts insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite. Turning semaglutide into a pill was a technical challenge, because peptides are normally broken down in the stomach. Rybelsus uses an absorption enhancer (SNAC) that protects the drug and helps it cross the stomach lining. Even so, only about 1% of each dose is absorbed, which is why the dosing rules are so strict.

Dosing and how to take them

Rybelsus

• Start at 3 mg once daily for 30 days. This starting dose is to reduce stomach side effects, not to control blood sugar.
• Increase to 7 mg once daily.
• If more control is needed after 30 days, increase to 14 mg.

How to take each dose:

• take it first thing in the morning on an empty stomach
• swallow it whole with no more than 4 oz (120 mL) of plain water
• wait at least 30 minutes before eating, drinking anything else or taking other oral medicines
• don’t split, crush or chew it

Taking it with food or too much water can sharply reduce how much is absorbed.

The newer tablets (now called Ozempic tablets)

In late 2024 the FDA approved a better-absorbed formulation in 1.5 mg, 4 mg and 9 mg strengths. Since January 2026, those strengths are labeled as Ozempic tablets, while Rybelsus refers to the 3, 7 and 14 mg tablets. The equivalent doses are:

Rybelsus (original)	Ozempic tablets (newer formulation)
3 mg (starting)	1.5 mg
7 mg	4 mg
14 mg	9 mg

Never use both at once, and never assume the numbers are interchangeable. A pharmacist should confirm any switch.

Metformin

• Usually starts at 500 mg once or twice daily with meals, increasing slowly every week or two to reduce stomach upset.
• Common maintenance doses are 1,500 to 2,000 mg a day.
• Extended-release (ER) metformin is taken once daily with the evening meal and is often easier on the stomach.

Effectiveness

Blood sugar

In the PIONEER trials, oral semaglutide 14 mg lowered HbA1c by about 1.0 to 1.4 points over 26 to 52 weeks. It outperformed sitagliptin (Januvia) and empagliflozin (Jardiance) on HbA1c. Metformin typically lowers HbA1c by 1 to 1.5 points as a first treatment. Both are effective; the size of the drop depends on how high blood sugar was to start with.

Weight

Rybelsus usually causes modest weight loss, about 2 to 4 kg at 14 mg. Metformin is weight-neutral or causes slight loss. Neither is approved as a weight-loss drug. The oral semaglutide product approved for weight management is Wegovy tablets at 25 mg daily.

Heart

• SOUL (oral semaglutide): in 9,650 adults with type 2 diabetes and established cardiovascular or chronic kidney disease, oral semaglutide 14 mg reduced major cardiovascular events by 14% compared with placebo. In October 2025, the FDA added a heart-risk reduction indication to Rybelsus.
• Metformin: the UKPDS study in the 1990s found lower heart attack and death rates in overweight people starting metformin, and decades of experience support its safety. However, it has no modern placebo-controlled heart outcomes trial.

Using Rybelsus and metformin together

The two are often combined, and the combination is well studied. In most PIONEER trials, people were already taking metformin. Together they lower blood sugar more than either alone, with low risk of hypoglycemia, because neither directly forces insulin release when sugar is normal.

Current American Diabetes Association guidance still lists metformin as a common starting drug, but recommends a GLP-1 receptor agonist or an SGLT2 inhibitor with proven heart or kidney benefit for people with established cardiovascular disease, heart failure, chronic kidney disease or high cardiovascular risk, whatever their HbA1c, and often alongside metformin.

Side effects

Rybelsus

• nausea (the most common), diarrhea, vomiting, stomach pain and constipation, mostly early on
• reduced appetite
• slight increase in heart rate
• serious but uncommon: pancreatitis, gallbladder disease, kidney injury from dehydration, worsening diabetic retinopathy in people with existing eye disease
• boxed warning: thyroid C-cell tumors in rodents. Don’t use if you or a family member has had medullary thyroid carcinoma or you have MEN 2.

Metformin

• diarrhea, nausea, gas, bloating and a metallic taste, especially at the start
• vitamin B12 deficiency with long-term use, which can contribute to anemia and nerve damage; B12 levels should be checked periodically
• lactic acidosis (boxed warning): very rare but serious, mainly in people with severe kidney disease, liver disease, heavy alcohol use, severe illness or dehydration

Kidney function and other cautions

	Rybelsus	Metformin
Kidney disease	No dose change needed; watch for dehydration	Don’t start if eGFR is 30 to 45; stop if eGFR falls below 30
Liver disease	No dose change needed	Avoid in significant liver disease
Contrast dye scans	No specific rule	May need to pause around iodinated contrast in some people
Alcohol	Moderate amounts usually fine	Heavy drinking raises lactic acidosis risk
Pregnancy	Stop at least 2 months before planned pregnancy	Sometimes used in pregnancy under specialist care
Other pills	Can reduce absorption of medicines taken in the 30-minute window; levothyroxine levels can rise	Few major interactions

Cost

• Metformin is one of the cheapest prescription medicines available, often a few dollars a month.
• Rybelsus is brand-only and expensive at list price. Insurance usually covers it for type 2 diabetes, sometimes only after metformin. Novo Nordisk runs savings programs for eligible people with commercial insurance.

Who might choose which?

Your situation	Typical approach
Newly diagnosed type 2 diabetes, no heart or kidney disease	Metformin first
Established heart disease or high cardiovascular risk	Add a GLP-1 drug (such as Rybelsus) or an SGLT2 inhibitor, often with metformin
Want weight loss as well as sugar control	Rybelsus, or an injectable GLP-1 or tirzepatide
Prefer a pill to an injection	Rybelsus (or Ozempic tablets) rather than injectable GLP-1 drugs
Severe kidney disease (eGFR under 30)	Not metformin; Rybelsus may be an option
Cost is the main concern	Metformin
Can’t manage strict morning dosing rules	Metformin, or a weekly GLP-1 injection

Frequently asked questions

Is Rybelsus better than metformin?

Not for everyone. Both lower blood sugar by similar amounts. Rybelsus usually causes more weight loss and is approved to lower heart risk in high-risk people, but it costs far more and has strict dosing rules. Metformin remains a common, inexpensive first choice and is often taken alongside Rybelsus.

Can you take Rybelsus and metformin together?

Yes. The combination is common and was tested in most of the main Rybelsus trials. It lowers blood sugar more than either drug alone with a low risk of hypoglycemia.

How should I take Rybelsus?

Take it first thing in the morning on an empty stomach with no more than 4 oz (120 mL) of plain water, then wait at least 30 minutes before eating, drinking or taking other medicines. Swallow it whole.

Is Rybelsus the same as Ozempic?

Both contain semaglutide. Ozempic is best known as a weekly injection. Since 2026, a newer, better-absorbed tablet formulation (1.5, 4 and 9 mg) is also sold as Ozempic tablets, while Rybelsus refers to the 3, 7 and 14 mg tablets. The tablets are not interchangeable milligram for milligram.

Does Rybelsus cause weight loss?

Usually modest weight loss of about 2 to 4 kg at the 14 mg dose. It isn’t approved for weight loss; Wegovy tablets (25 mg) are the oral semaglutide approved for weight management.

Why do I need vitamin B12 checks on metformin?

Long-term metformin can reduce vitamin B12 absorption, which can cause anemia or nerve symptoms such as numbness. Periodic B12 checks are recommended, especially after several years or if symptoms develop.

References

• FDA. RYBELSUS and OZEMPIC tablets prescribing information, revised 2026
• FDA. RYBELSUS prescribing information with SOUL cardiovascular indication, revised 10/2025
• DailyMed. Metformin hydrochloride tablets label
• McGuire DK, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes (SOUL). N Engl J Med. 2025;392:2001-2012
• European Medicines Agency. Rybelsus: risk of medication error due to new tablet formulation, 2025
• American Diabetes Association. Standards of Care in Diabetes: pharmacologic approaches to glycemic treatment